PEPTONIC MEDICAL AB
NNGM:PMED0.00
SEK
0.00
(0.00%)
PEPTONIC MEDICAL AB
NGM:PMED
(Nordic Growth Market)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Peptonic Medical AB is a Sweden-based biomedical and medical technology company dedicated to developing, manufacturing, and commercializing clinically proven self-care products, diagnostic tests, and medical devices focused on women's intimate health and femtech solutions. Founded in 2009 and headquartered in Stockholm, Sweden, the company operates primarily across the consumer healthcare, medical technology, and in vitro diagnostic segments, catering to women across various life stages including menstruation, pregnancy, and menopause. The company offers a comprehensive range of proprietary and commercialized products, including the VagiVital brand portfolio; VagiVital AktivGel, a clinically validated, hormone-free medical device gel for the treatment of vaginal atrophy and dryness; VagiVital VS, an at-home diagnostic self-test that distinguishes between bacterial vaginosis and fungal infections; VagiVital Menopause, a rapid follicle-stimulating hormone (FSH) self-test to detect perimenopause and menopause onset; VagiVital AL, a diagnostic test for detecting amniotic fluid leakage during pregnancy; VagiVital Moisturizing Intimate Cleanser, a specialized cleansing foam for intimate hygiene; the Lunette brand portfolio, comprising reusable medical-grade silicone menstrual cups in various sizes; organic menstrual cup cleansing washes; intimate hygiene wipes; reusable period care accessories; Vernavia, a treatment solution targeting bacterial vaginosis; and contract development, technology licensing, and commercial distribution support services provided to international healthcare partners. Peptonic Medical AB distributes its products through community pharmacies, grocery retailers, specialized e-commerce platforms, gynecological practices, and direct-to-consumer channels across the Nordic region, Continental Europe, North America, and selected international markets via local distributors and subsidiaries, including Lune Group Oy. In recent strategic and corporate developments, Peptonic Medical AB has undertaken major organizational and operational realignments to optimize its cost structure, consolidate its supply chain, and accelerate the commercialization of its core brands. The company has advanced its international expansion by strengthening retail and digital distribution networks for VagiVital and Lunette in the United States and key European markets through strategic distribution agreements and expanded e-commerce availability. To support its commercial rollout, meet European Union Medical Device Regulation (MDR) compliance standards, and strengthen working capital, Peptonic Medical executed capital enhancement initiatives through rights issues. Additionally, the company integrated its Finnish subsidiary Lune Group Oy to streamline joint administrative, marketing, and logistics operations, while expanding its diagnostic self-care footprint through new pharmacy distribution listings across Europe.